These Healthcare stocks are trading higher:
-Rezolute Inc (RZLT) stock is trading at $11.16, a gain of $3.47, or 43.08%, on high volume. Rezolute Inc gets a Sentiment Score of Very Bullish from InvestorsObserver and receives an average analyst recommendation of Strong Buy with a price target of $25.50.
-Syros Pharmaceuticals Inc (SYRS) stock is trading at $6.63, a gain of $1.03, or 18.5%, on high volume. Syros Pharmaceuticals gets a Sentiment Score of Bullish from InvestorsObserver and receives an average analyst recommendation of Strong Buy with a price target of $16.67.
-Pieris Pharmaceuticals Inc (PIRS) stock is trading at $3.95, an increase of $0.55, or 16.37%, on moderate volume. Pieris Pharma gets a Sentiment Score of Bearish from InvestorsObserver and receives an average analyst recommendation of Strong Buy with a price target of $7.50.
-Immunome Inc (IMNM) stock is trading at $22.68, a rise of $3.05, or 15.38%, on moderate volume. Immunome Inc gets a Sentiment Score of Bullish from InvestorsObserver and receives an average analyst recommendation of Strong Buy with a price target of $36.00.
Find the top stocks in the Healthcare Sector here.
These Healthcare stocks are trading lower:
-Nextgen Healthcare Inc (NXGN) stock is trading at $16.10, a loss of $2.62, or 14%, on high volume. Nextgen Healthcare Inc gets a Sentiment Score of Very Bullish from InvestorsObserver and receives an average analyst recommendation of Buy with a price target of $21.44.
-Novan Inc (NOVN) stock is trading at $7.93, a loss of $1.26, or 13.82%, on high volume. Novan Inc gets a Sentiment Score of Bullish from InvestorsObserver and receives an average analyst recommendation of Strong Buy with a price target of $3.17.
-Lynx Global Digital Finance Corp (CNONF) stock is trading at $0.97, a decline of $0.13, or 11.82%, on high volume. Lynx Global Digital Fin Corp gets a Sentiment Score of Very Bearish from InvestorsObserver and receives an average analyst recommendation of Strong Sell.
-Protagenic Therapeutics Inc (PTIX) stock is trading at $2.42, a decline of $0.27, or 10.1%, on low volume. Protagenic Therapeutics Inc gets a Sentiment Score of Very Bearish from InvestorsObserver and receives an average analyst recommendation of Strong Sell. Protagenic Therapeutics Inc next reports earnings on June 17.
